These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24851355)

  • 1. [Levothyroxine and generics: current reflections].
    Orgiazzi J; Wémeau JL
    Rev Prat; 2014 Mar; 64(3):304-6. PubMed ID: 24851355
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preventable problems in thyroid hormone substitution therapy. The risks of brand change are unpredictable].
    MMW Fortschr Med; 2010 Jun; 152(22):46-7. PubMed ID: 20590034
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prescribing levothyroxine. Preparation hopping risks accurate regulation].
    MMW Fortschr Med; 2009 Mar; 151(12):37. PubMed ID: 19475856
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.
    Dong BJ; Hauck WW; Gambertoglio JG; Gee L; White JR; Bubp JL; Greenspan FS
    JAMA; 1997 Apr; 277(15):1205-13. PubMed ID: 9103344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary hypothyroidism: Considerations for a rational use of levothyroxine therapy].
    Bros JA; Lluís PG; Cabot GL; Pedragós AC
    Med Clin (Barc); 2011 Feb; 136(5):207-14. PubMed ID: 19646718
    [No Abstract]   [Full Text] [Related]  

  • 6. Generic levothyroxine.
    Med Lett Drugs Ther; 2004 Sep; 46(1192):77-8. PubMed ID: 15452463
    [No Abstract]   [Full Text] [Related]  

  • 7. Generic vs name brand L-thyroxine products: interchangeable or still not?
    Hennessey JV
    J Clin Endocrinol Metab; 2013 Feb; 98(2):511-4. PubMed ID: 23390262
    [No Abstract]   [Full Text] [Related]  

  • 8. Two cases of therapeutic failure associated with levothyroxine brand interchange.
    Copeland PM
    Ann Pharmacother; 1995 May; 29(5):482-5. PubMed ID: 7655130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current status of the treatment with thyroid hormones].
    Laudo Pardos C; Puigdevall Gallego V; del Río Mayor MJ; Velasco Martín A
    An Med Interna; 1996 Nov; 13(11):555-61. PubMed ID: 9019218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Levothyroxine malabsortion].
    Catalina PF; Carpio D
    Med Clin (Barc); 2015 Jul; 145(1):46. PubMed ID: 25458511
    [No Abstract]   [Full Text] [Related]  

  • 11. Thyroid storm.
    Rennie D
    JAMA; 1997 Apr; 277(15):1238-43. PubMed ID: 9103350
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for interference with the intestinal absorption of levothyroxine sodium by aluminum hydroxide.
    Sperber AD; Liel Y
    Arch Intern Med; 1992 Jan; 152(1):183-4. PubMed ID: 1728914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal absorption and buccal absorption of liquid levothyroxine.
    Benvenga S; Di Bari F
    Endocrine; 2017 Dec; 58(3):591-594. PubMed ID: 28271396
    [No Abstract]   [Full Text] [Related]  

  • 14. Levothyroxine in psychiatry: issues related to absorption after oral dosing.
    Andrade C
    J Clin Psychiatry; 2013 Aug; 74(8):e744-6. PubMed ID: 24021514
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioequivalence of generic preparations of levothyroxine.
    Toft A
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):603; author reply 603-4. PubMed ID: 19508682
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased thyroid-stimulating hormone levels associated with concomitant administration of levothyroxine and raloxifene.
    Garwood CL; Van Schepen KA; McDonough RP; Sullivan AL
    Pharmacotherapy; 2006 Jun; 26(6):881-5. PubMed ID: 16716142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New questions regarding bioequivalence of levothyroxine preparations: a clinician's response.
    Green WL
    AAPS J; 2005 Mar; 7(1):E54-8. PubMed ID: 16146330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferrous sulfate-induced increase in requirement for thyroxine in a patient with primary hypothyroidism.
    Shakir KM; Chute JP; Aprill BS; Lazarus AA
    South Med J; 1997 Jun; 90(6):637-9. PubMed ID: 9191742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism.
    Alexander EK; Marqusee E; Lawrence J; Jarolim P; Fischer GA; Larsen PR
    N Engl J Med; 2004 Jul; 351(3):241-9. PubMed ID: 15254282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption kinetics of levothyroxine is not altered by proton-pump inhibitor therapy.
    Dietrich JW; Gieselbrecht K; Holl RW; Boehm BO
    Horm Metab Res; 2006 Jan; 38(1):57-9. PubMed ID: 16477543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.